Intractable duodenal ulceration

References

• Howden CW, Jones DB, Hunt RH. Nocturnal doses of H2 receptor antagonists for duodenal ulcer. (Letter) Lancet 1985: 1(8429): 647–8
   PubMed Web of Science ®Google Scholar
• Sonnenberg A, Muller-Lissner SA, Vogel E, et al. Predictors of duodenal ulcer healing and relapse. Gastroenterology 1981: 81(6): 1061–7
   PubMed Web of Science ®Google Scholar
• Lam SK, Koo J. Accurate prediction of duodenal-ulcer healing rate by discriminant analysis. Gastroenterology 1983: 85(2): 403–12
   PubMed Web of Science ®Google Scholar
• Lam SK, Lai CL, Lee LN, et al. Factors influencing healing of duodenal ulcer: control of nocturnal secretion by H2 blockade and characteristics of patients who failed to heal. Dig Dis Sci 1985: 30(1): 45–51
   PubMed Web of Science ®Google Scholar
• Galmiche JP, Tranvouez JL, Denis P, et al. Does nocturnal monitoring of gastric pH permit the prediction of therapeutic response in severe duodenal ulcer treated with ranitidine? Gastroenterol Clin Biol 1985: 9(8–9): 583–9
   PubMedGoogle Scholar
• Gledhill T, Bock M, Paul A, et al. Cimetidine or vagotomy? Comparison of the effects of proximal gastric vagotomy. Cimetidine and placebo on nocturnal intragastric acidity and acid secretion in patients with cimetidine resistant duodenal ulcer. Br J Surg 1983: 70(12): 704–6
   PubMed Web of Science ®Google Scholar
• Hunt RH, Howden CW, Jones DB, et al. The correlation between acid suppression and peptic ulcer healing. Scand J Gastroenterol 1986: 125(Suppl): 22–31
   Web of Science ®Google Scholar
• Richardson CT, Peters MN, Feldman M, et al. Treatment of Zollinger-Elison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists: a prospective study. Gastroenterology 1985: 89(2): 357–67
   PubMed Web of Science ®Google Scholar
• Cockel R. Diseases of the duodenum. In: Misiewicz JJ, Pounder RE, Venables C, eds. Diseases of the gut and pancreas. St Louis: CV Mosby (Blackwell Scientific) 1987: 404–18
   Google Scholar
• Bardhan KD. Refractory duodenal ulcer. Gut 1984: 25(7): 711–7
   PubMed Web of Science ®Google Scholar
• Quatrini M, Basilisco G, Bianchi PA. Treatment of “cimetidine-resistant” chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study. Gut 1984: 25(10): 1113–7
   PubMed Web of Science ®Google Scholar
• Amouretti M, Ansenay M, Bader JP, et al. Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine: multicentre controlled therapeutic trial. Gastroenterol Clin Biol 1985: 9(2): 147–52
   PubMedGoogle Scholar
• Sharma BK, Walt RP, Pounder RE, et al. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984: 25(9): 957–64
   PubMed Web of Science ®Google Scholar
• Classen M, Dammann HG, Domschke W, et al. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine: results of two German multicentre trials. Hepatogastroenterology 1985: 32(5): 243–5
   PubMed Web of Science ®Google Scholar
• Lauritsen K, Rune SJ, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer: a double-blind comparative trial. N Engl J Med 1985: 312(15): 958–61
   PubMed Web of Science ®Google Scholar
• Bardban KD, Bianchi Porro G, Bose K, et al. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986: 8(4): 408–13
   PubMed Web of Science ®Google Scholar
• Tytgat GN, Lamers CB, Hameeteman W, et al. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists. Aliment Pharmacol Therapeut 1987: 1(1): 31–8
   PubMedGoogle Scholar
• Lanzon-Miller S, Pounder RE, Chronos NA, et al. Can high dose oral ranitidine eliminate intragastric acid and what does it do to plasma gastrin? Gastroenterology 1987: 92(5): A1491
   Google Scholar
• Santana IA, Lanzon-Miller S, Pounder RE. Effect of oral famotidine on 24-hour intragastric acidity. Postgrad Med J 1986: 62(Suppl 2): 39–42
   PubMedGoogle Scholar
• Gledhill T, Buck M, Hunt RH. Effect of no treatment, cimetidine 1 g/day, cimetidine 2g/day and cimetidine combined with atropine on nocturnal gastric secretion in cimetidine non-responders. Gut 1984: 25(11): 1211–6
   PubMed Web of Science ®Google Scholar
• Pounder RE, Hunt RH, Vincent SH, et al. 24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. Gut 1977: 18(2): 85–90
   PubMed Web of Science ®Google Scholar
• Peterson WL, Barnett C, Feldman M, et al. Reduction of twenty-four-hour gastric acidity with combination drug therapy in patients with duodenal ulcer. Gastroenterology 1979: 77(5): 1015–20
   PubMed Web of Science ®Google Scholar
• Londong W, Londong V, Prechtl R, et al. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man. Scand J Gastroenterol 1980: 66(Suppl): 103–14
   Google Scholar
• Londong W, Londong V, Ruthe C, et al. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine. Gut 1981: 22(7): 542–8
   PubMed Web of Science ®Google Scholar
• Williams JG, Deakin M, Ramage JK. Effect of cimetidine and pirenzepine in combination on 24 hour intragastric acidity in subjects with previous duodenal ulceration. Gut 1986: 27(4): 428–32
   PubMed Web of Science ®Google Scholar
• Mahachai V, Jamali F, Reilly P, et al. Combination of pirenzepine and cimetidine on gastric acidity and gastrin profile in patients with duodenal ulcer disease. Gastroenterology 1984: 86(5): A1171
   Google Scholar
• Dal Monte PR, D'Imperio M, Ferri M. et al. A combination of pirenzepine and cimetidine: a new approach to treatment of duodenal ulcer in “non-responders.” Hepatogastroenterology 1985: 32(3): 126–8
   PubMed Web of Science ®Google Scholar
• Lam SK, Lee NW, Koo J, et al. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine. Gut 1984: 25(7)703–6
   PubMed Web of Science ®Google Scholar
• Gear MW. Maintenance treatment: surgery as an alternative. In: Baron JH, ed. Cimetidine in the 80s. Edinburgh: Churchill Livingstone, 1981: 85–8
   Google Scholar
• Hansen JH, Knigge U. Failure of proximal gastric vagotomy for duodenal ulcer resistant to cimetidine. Lancet 1984: 2(8394): 84–6
   PubMed Web of Science ®Google Scholar
• Bardhan KD, Kapur B, Hinchliffe RF. Cimetidine or vagotomy? (Letter) Br J Surg 1984: 71(5): 402–3
   PubMed Web of Science ®Google Scholar
• Gledhill T, Mills J, Borland WL, et al. Studies on the cimetidine resistant duodenal ulcer: a summary of work performed at the Royal Naval Hospital, Haslar. J R Nav MedServ 1984: 70(2): 70–81
   PubMedGoogle Scholar
• Vagotomy for cimetidine resistant ulcers. (Letter) Lancet 1984: 2(8404): 697–8
   Google Scholar
• Pickard WR, MacKay C. Early results of surgery in patients considered cimetidine failures. Br J Surg 1984: 71(1): 67–8
   PubMed Web of Science ®Google Scholar
• Hoffman J, Jensen HE. Failure of proximal gastric vagotomy for duodenal ulcer resistant to cimetidine. (Letter) Lancet 1984: 2(8398): 357
   PubMed Web of Science ®Google Scholar
• Weaver RM, Temple JG. Proximal gastric vagotomy in patients resistant to cimetidine. Br J Surg 1985: 72(3): 177–8
   PubMed Web of Science ®Google Scholar
• Primrose JN, Axon AT, Johnston D. Highly selective vagotomy (HSV) and duodenal ulcers resistant to H2-blockers. Gut 1986: 27(5): A1282
   Google Scholar
• Pounder RE. Model of medical treatment for duodenal ulcer. Lancet 1981: 1(8210): 29–30
   PubMed Web of Science ®Google Scholar
• Sonnenberg A. Comparison of different strategies for treatment of duodenal ulcer. Br Med J (Clin Res) 1985: 290(6476): 1185–7
   PubMedGoogle Scholar
• McLean AJ, Harrison PM, Byrne AJ, et al. Relapse rates are more important than healing rates in determining the long-term outcome of duodenal ulcer therapy. (Letter) Gastroenterology 1985: 89(2): 480–2
   PubMed Web of Science ®Google Scholar